Ridloff Elena — SEC Form 4 filings

SEC reporting owner CIK 1772518. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-06-20 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kymera Therapeutics, Inc. (KYMR)Director77 legs · 31,500 sh · $2,063,86013
Sionna Therapeutics, Inc. (SION)CFO and CBO67 legs · 85,000 sh · $1,966,6346
Kronos Bio, Inc. (KRON)Director29
IMMUNIC, INC. (IMUX)Director11

Form 4 filings — Ridloff Elena

FiledFormIssuerReported transactionsSource
2026-09-184Sionna Therapeutics, Inc. (SION)Grant/award (A): 47,269 @ $0 · Grant/award (A): 47,268 @ $0 · Grant/award (A): 165,440 (derivative) @ $0 · Disposition to issuer (D): 165,440 (derivative) @ $0EDGAR
2026-08-104IMMUNIC, INC. (IMUX)Grant/award (A): 50,740 (derivative) @ $0EDGAR
2026-06-254Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 6,068 (derivative) @ $0EDGAR
2026-05-114Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 3,000 @ $31.20 · Sale (S): 3,000 @ $87 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-04-014Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 7,400 @ $14.18 · Sale (S): 7,400 @ $85.37 · Option exercise (M): 4,600 @ $14.18 · Sale (S): 3,400 @ $85.19 · Sale (S): 1,200 @ $86.05 · Option exercise (M): 7,400 (derivative) @ $0 · +1 moreEDGAR
2026-01-064Sionna Therapeutics, Inc. (SION)Grant/award (A): 165,440 (derivative) @ $0EDGAR
2025-09-034Sionna Therapeutics, Inc. (SION)Sale (S): 748 @ $25.18 · Sale (S): 8,836 @ $25.08EDGAR
2025-08-284Sionna Therapeutics, Inc. (SION)Sale (S): 3,700 @ $25.13 · Sale (S): 3,618 @ $25.10 · Sale (S): 16,098 @ $25.97EDGAR
2025-08-214Sionna Therapeutics, Inc. (SION)Sale (S): 34,500 @ $21.08 · Sale (S): 17,500 @ $22.69EDGAR
2025-06-264Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-06-204Kronos Bio, Inc. (KRON)Code (U): 25,296 @ $0.57 · Disposition to issuer (D): 25,879 (derivative) @ $0 · Disposition to issuer (D): 26,871 (derivative) @ $0 · Disposition to issuer (D): 15,450 (derivative) @ $0 · Disposition to issuer (D): 34,000 (derivative) @ $0 · Disposition to issuer (D): 17,000 (derivative) @ $0 · +1 moreEDGAR
2025-06-114Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 4,500 @ $20.29 · Sale (S): 4,500 @ $50 · Option exercise (M): 4,500 (derivative) @ $0EDGAR
2025-06-034Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 12,000 @ $27.67 · Sale (S): 7,200 @ $45.50 · Sale (S): 4,800 @ $47 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2025-02-104Sionna Therapeutics, Inc. (SION)Grant/award (A): 157,820 (derivative) @ $0EDGAR
2024-06-264Kronos Bio, Inc. (KRON)Grant/award (A): 11,333 @ $0 · Grant/award (A): 17,000 (derivative) @ $0EDGAR
2024-06-204Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 16,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1772518 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →